Cargando…
Thyrotropin Receptor Antibody (TRAb)-IgM Levels Are Markedly Higher Than TRAb-IgG Levels in Graves' Disease Patients and Controls, and TRAb-IgM Production Is Related to Epstein–Barr Virus Reactivation
Graves' disease is an autoimmune thyroid disorder that mainly presents as hyperthyroidism and is caused by thyrotropin receptor antibodies (TRAbs) that stimulate thyroid-stimulating hormone receptors. We previously reported that Graves' disease patients and healthy controls both had Epstei...
Autores principales: | Kumata, Keisuke, Nagata, Keiko, Matsushita, Michiko, Kuwamoto, Satoshi, Kato, Masako, Murakami, Ichiro, Fukata, Shuji, Hayashi, Kazuhiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7307640/ https://www.ncbi.nlm.nih.gov/pubmed/27529807 http://dx.doi.org/10.1089/vim.2016.0043 |
Ejemplares similares
-
SAT-555 Cytotoxicity of Epstein-Barr Virus Reactivation-Induced TRAb-IgM to Thyrocytes
por: Nagata, Keiko, et al.
Publicado: (2019) -
Increased risk of Graves´ophthalmopathy in patients with increasing TRAb after radioiodine treatment and the impact of CTLA4 on TRAb titres
por: Shahida, Bushra, et al.
Publicado: (2021) -
The effect of radioiodine treatment on the characteristics of TRAb in Graves’ disease
por: Fang, Ya, et al.
Publicado: (2021) -
SAT462 TSI Versus TRAb In The Diagnosis Of Grave’s Disease
por: Ibrahim, Katherine, et al.
Publicado: (2023) -
Serum and thyroid tissue level of let-7b and their correlation with TRAb in Graves’ disease
por: Chen, Xinxin, et al.
Publicado: (2018)